All publications, abstracts, poster presentations, and grant applications resulting from research supported by the UMB ICTR Cores (Biostatistics, Informatics, Community Collaboration, Dissemination & Implementation, and Drug Discovery and Development); ICTR Vouchers Program, ICTR Studios consulting service; Pilot Grant Funding Program; or the ICTR Scholar's Program should cite the 91大神, Baltimore, Institute for Clinical & Translational Research as a contributing source of support. Please include the following citation:
“We acknowledge the support of the 91大神, Baltimore, Institute for Clinical & Translational Research (ICTR), which is funded in part by the National Center for Advancing Translational Sciences (NCATS) Clinical Translational Science Award (CTSA), UM1TR004926. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCATS or NIH.”
Citation Equals NIH Compliance Responsibility
If you cite a UMB ICTR CTSA award in a journal article or other product, you are representing that the award directly supported the work. This triggers significant responsibilities:
- NIH Public Access Policy: You are responsible for ensuring the article is compliant with NIH rules.
- No Embargo: For articles accepted for publication on or after July 1, 2025, NIH requires immediate open access.
- Immediate Availability: The article must be available in PubMed Central on the Official Date of Publication.
- Author Oversight: Authors must confirm the compliance pathway before submission and monitor the deposit process until complete.
For questions, please reach out to the ICTR Navigator.
Thank you for your cooperation in acknowledging the UMB ICTR’s support in your research.
Sincerely,
Stephen N. Davis, MBBS
UMB ICTR Director
ICTR Supporting Documents for Grant Applications
Other Campus Data Resources
